ASHLAND, Mass., March 14, 2025 /PRNewswire/ — BioSurfaces, a leader in advanced nanofiber materials, and Morphocell Technologies, a regenerative medicine company, are pleased to announce a collaboration aimed at exploring the potential of BioSurfaces’ proprietary Bio-Spun™ material for therapeutic applications.
The partnership will focus on leveraging Bio-Spun™’s unique properties to advance innovations in regenerative medicine. By combining BioSurfaces’ expertise in biomaterials with Morphocell’s deep knowledge in cell-based therapies, the companies seek to develop new solutions that address critical healthcare challenges.
“At Morphocell, we are always looking for cutting-edge technologies that can help us improve patient outcomes,” said Dr. Massimiliano Paganelli, CEO of Morphocell. “BioSurfaces has developed an exciting material, and we look forward to working together to explore its potential in advancing therapeutic approaches for patients in need.”
Matthew Phaneuf, President and CEO of BioSurfaces, added: “We are excited to collaborate with Morphocell, a company at the forefront of regenerative medicine. Our shared mission is to innovate and develop solutions that can ultimately improve lives. This partnership represents an important step in that direction.”
The collaboration will focus on early-stage research efforts to evaluate Bio-Spun™ in various therapeutic applications, with the long-term vision of contributing to the advancement of regenerative treatments for patients worldwide.
About BioSurfaces
BioSurfaces, based in Ashland, Massachusetts, is focused on improving lives throughout the world by applying our unique Bio-Spun™ nanofiber materials paired with our decades of expertise to support the development and commercialization of a range of products that are superior to those available today. Bio-Spun™ technology creates solutions by engineering biology with synthetic cellular matrices. We continue to drive innovation in applications related to life science benchtop tools, stand-alone or combination medical devices and consumer products. We collaborate with some of the world’s leading life science organizations working in these areas.
About Morphocell Technologies
Morphocell Technologies is a Montreal-based regenerative medicine company developing cell therapies and engineered tissues for the treatment of severe organ deficiencies. The company is committed to advancing groundbreaking solutions to address critical patient needs. (www.morphocell.com)
SOURCE BioSurfaces, LLC
Funding from the Kissick Family Foundation Expands Frontotemporal Dementia Data; New Partnership with The Michael J. Fox Foundation Enhances Parkinson's Research OAKLAND, Calif., May…
Healthcare IT and community health leader to scale company's footprint and deepen impact in community-based…
HELSINKI, May 20, 2025 /PRNewswire/ -- New research presented today at the European Stroke Organisation…
Codoxo's Point Zero approach creates an entirely new space in payment integrity—before claims are ever…
Toronto, Ontario--(Newsfile Corp. - May 20, 2025) - Bloom Burton & Co. Inc. (Bloom Burton)…
COSTA MESA, Calif.--(BUSINESS WIRE)--TadHealth, a leading provider of school-based mental health technology, is proud to…
![](data:image/svg+xml;charset=utf-8,<svg height="32px" width="32px" xmlns="http://www.w3.org/2000/svg" version="1.1"/>)
![](data:image/svg+xml;charset=utf-8,<svg height="284px" width="400px" xmlns="http://www.w3.org/2000/svg" version="1.1"/>)
![](data:image/svg+xml;charset=utf-8,<svg height="12px" width="12px" xmlns="http://www.w3.org/2000/svg" version="1.1"/>)
![](data:image/svg+xml;charset=utf-8,<svg height="400px" width="1000px" xmlns="http://www.w3.org/2000/svg" version="1.1"/>)
